Myelitis due to schistosoma species (Q86633): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Distúrbio inflamatório da medula espinal devido à infecção por uma espécie esquistossomótica. Os sintomas e sinais podem ser agudos ou subagudos no início e incluem paraparesia ou paraplegia, perda sensorial apropriada com o nível da medula espinhal afetada, perda do controle do esfíncter e sinais do neurônio motor inferior. O diagnóstico pode ser confirmado por neuroimagem, análise do líquido espinal, testes sorológicos e biópsia
description / endescription / en
 
An inflammatory disorder of the spinal cord due to infection by a schistosomal species. The symptoms and signs may be acute or subacute in onset, and include paraparesis or paraplegia, sensory loss appropriate with the level of the spinal cord affected, loss of sphincter control, and lower motor neurone signs. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis, serological tests, and biopsy.

Revision as of 12:04, 15 August 2026

An inflammatory disorder of the spinal cord due to infection by a schistosomal species. The symptoms and signs may be acute or subacute in onset, and include paraparesis or paraplegia, sensory loss appropriate with the level of the spinal cord affected, loss of sphincter control, and lower motor neurone signs. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis, serological tests, and biopsy.
Language Label Description Also known as
default for all languages
ID_37486018
    English
    Myelitis due to schistosoma species
    An inflammatory disorder of the spinal cord due to infection by a schistosomal species. The symptoms and signs may be acute or subacute in onset, and include paraparesis or paraplegia, sensory loss appropriate with the level of the spinal cord affected, loss of sphincter control, and lower motor neurone signs. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis, serological tests, and biopsy.

      Statements